ACE2 and cancer: Indeed, ADAM17 expression has been shown to be downregulated by the application of vandetanib, an EGFR TKI in clinical use.9 Apart from the above-mentioned effects of cancer treatments on the two proteases regulating ACE2 processing, other extrinsic variables may also play a significant role in virus infectiousness.